Mednet Logo
HomeNephrologyQuestion

Is there a role for SGLT-2 inhibitors in the treatment of chronic hypomagnesemia?

1 Answers
Mednet Member
Mednet Member
Nephrology · UCLA

A meta-analysis of 18 randomized controlled trials showed that the use of SGLT2 inhibitors can result in a significant increase in the serum magnesium level. These trials, however, were not specifically designed to assess the effect of SGLT2 inhibitors on the serum magnesium level.

Studies have show...

Register or Sign In to see full answer